论文部分内容阅读
对丙型肝炎患者来说,Albuferon 治疗可能比聚乙二醇化干扰素用药次数少,不良反应小。人类基因组科学公司(Human Genome Sciences Inc．)5月1日宣布, 其治疗丙型肝炎的实验性药物
For patients with hepatitis C, Albuferon treatment may be less than the number of pegylated interferon medication, adverse reactions. Human Genome Sciences Inc. announced on May 1 that its experimental drug for the treatment of hepatitis C